APA

Palma Gámiz J. L., Pêgo M., Contreras E. M., Anglada M. P., Martínez J. O., Esquerra E. A. & Sagastagoitia Gorostiza J. D. (20070313). A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH). : Clinical therapeutics.

Chicago

Palma Gámiz José Luis, Pêgo Mariano, Contreras Emilio Márquez, Anglada Montserrat Pujol, Martínez Josefina Oliván, Esquerra Eduardo Alegría and Sagastagoitia Gorostiza José Domingo. 20070313. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH). : Clinical therapeutics.

Harvard

Palma Gámiz J. L., Pêgo M., Contreras E. M., Anglada M. P., Martínez J. O., Esquerra E. A. and Sagastagoitia Gorostiza J. D. (20070313). A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH). : Clinical therapeutics.

MLA

Palma Gámiz José Luis, Pêgo Mariano, Contreras Emilio Márquez, Anglada Montserrat Pujol, Martínez Josefina Oliván, Esquerra Eduardo Alegría and Sagastagoitia Gorostiza José Domingo. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH). : Clinical therapeutics. 20070313.